The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125527981 12552798 1 I 201603 20160707 20160713 20160713 EXP FR-PFIZER INC-2016335197 PFIZER 46.00 YR F Y 0.00000 20160713 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125527981 12552798 1 PS Effexor LP VENLAFAXINE HYDROCHLORIDE 1 Oral 75 MG, 2X/DAY 20699 75 MG PROLONGED-RELEASE CAPSULE BID
125527981 12552798 2 SS TIVICAY DOLUTEGRAVIR SODIUM 1 Oral 100 MG (2 X 50 MG), 1X/DAY 1000 MG 0 100 MG FILM-COATED TABLET QD
125527981 12552798 3 SS LAROXYL AMITRIPTYLINE 1 Oral 50 MG, 2X/DAY 0 50 MG FILM-COATED TABLET BID
125527981 12552798 4 SS NORVIR RITONAVIR 1 Oral 200 MG (2 X 100 MG), 2X/DAY 4000 MG 0 200 MG FILM-COATED TABLET BID
125527981 12552798 5 SS TRUVADA EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE 1 Oral 1 DF, 1X/DAY 10 DF 0 1 DF FILM-COATED TABLET QD
125527981 12552798 6 SS APTIVUS TIPRANAVIR 1 Oral 250 MG, UNK 0 250 MG CAPSULE, SOFT
125527981 12552798 7 SS IMOVANE ZOPICLONE 1 Oral 7.5 MG, 1X/DAY 0 7.5 MG FILM-COATED TABLET QD
125527981 12552798 8 SS THERALENE TRIMEPRAZINE 1 Oral 5 MG, UNK 0 5 MG FILM-COATED TABLET
125527981 12552798 9 SS TERCIAN CYAMEMAZINE 1 Oral UNK 0
125527981 12552798 10 C LYSANXIA PRAZEPAM 1 UNK 0
125527981 12552798 11 C ISENTRESS RALTEGRAVIR POTASSIUM 1 UNK 0
125527981 12552798 12 C CELSENTRI MARAVIROC 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125527981 12552798 1 Depression
125527981 12552798 2 Acquired immunodeficiency syndrome
125527981 12552798 3 Depression
125527981 12552798 4 Acquired immunodeficiency syndrome
125527981 12552798 5 Acquired immunodeficiency syndrome
125527981 12552798 6 Acquired immunodeficiency syndrome
125527981 12552798 7 Insomnia
125527981 12552798 8 Depression
125527981 12552798 9 Depression
125527981 12552798 10 Depression
125527981 12552798 11 Acquired immunodeficiency syndrome
125527981 12552798 12 Acquired immunodeficiency syndrome

Outcome of event

Event ID CASEID OUTC COD
125527981 12552798 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
125527981 12552798 Completed suicide
125527981 12552798 Condition aggravated
125527981 12552798 Depression

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125527981 12552798 1 201504 20160323 0
125527981 12552798 2 20160314 20160323 0
125527981 12552798 3 201511 20160323 0
125527981 12552798 4 20160314 20160323 0
125527981 12552798 5 20160314 20160323 0
125527981 12552798 6 2013 20160323 0
125527981 12552798 7 201504 20160323 0
125527981 12552798 8 20160323 0
125527981 12552798 9 20160323 0
125527981 12552798 11 20160314 0
125527981 12552798 12 20160314 0